These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

664 related articles for article (PubMed ID: 21076407)

  • 1. A de novo paradigm for mental retardation.
    Vissers LE; de Ligt J; Gilissen C; Janssen I; Steehouwer M; de Vries P; van Lier B; Arts P; Wieskamp N; del Rosario M; van Bon BW; Hoischen A; de Vries BB; Brunner HG; Veltman JA
    Nat Genet; 2010 Dec; 42(12):1109-12. PubMed ID: 21076407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study.
    Rauch A; Wieczorek D; Graf E; Wieland T; Endele S; Schwarzmayr T; Albrecht B; Bartholdi D; Beygo J; Di Donato N; Dufke A; Cremer K; Hempel M; Horn D; Hoyer J; Joset P; Röpke A; Moog U; Riess A; Thiel CT; Tzschach A; Wiesener A; Wohlleber E; Zweier C; Ekici AB; Zink AM; Rump A; Meisinger C; Grallert H; Sticht H; Schenck A; Engels H; Rappold G; Schröck E; Wieacker P; Riess O; Meitinger T; Reis A; Strom TM
    Lancet; 2012 Nov; 380(9854):1674-82. PubMed ID: 23020937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-exome sequencing for finding de novo mutations in sporadic mental retardation.
    Robinson PN
    Genome Biol; 2010; 11(12):144. PubMed ID: 21172032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new paradigm emerges from the study of de novo mutations in the context of neurodevelopmental disease.
    Ku CS; Polychronakos C; Tan EK; Naidoo N; Pawitan Y; Roukos DH; Mort M; Cooper DN
    Mol Psychiatry; 2013 Feb; 18(2):141-53. PubMed ID: 22641181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of
    Gao ZJ; Jiang Q; Chen XL; Chen Q; Ji XN; Mao YY; Feng S; Dong JJ; Xu KM
    Zhonghua Yi Xue Za Zhi; 2018 Nov; 98(42):3426-3432. PubMed ID: 30440138
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnostic exome sequencing in persons with severe intellectual disability.
    de Ligt J; Willemsen MH; van Bon BW; Kleefstra T; Yntema HG; Kroes T; Vulto-van Silfhout AT; Koolen DA; de Vries P; Gilissen C; del Rosario M; Hoischen A; Scheffer H; de Vries BB; Brunner HG; Veltman JA; Vissers LE
    N Engl J Med; 2012 Nov; 367(20):1921-9. PubMed ID: 23033978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in HECW2 are associated with intellectual disability and epilepsy.
    Halvardson J; Zhao JJ; Zaghlool A; Wentzel C; Georgii-Hemming P; Månsson E; Ederth Sävmarker H; Brandberg G; Soussi Zander C; Thuresson AC; Feuk L
    J Med Genet; 2016 Oct; 53(10):697-704. PubMed ID: 27334371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation.
    Berkel S; Marshall CR; Weiss B; Howe J; Roeth R; Moog U; Endris V; Roberts W; Szatmari P; Pinto D; Bonin M; Riess A; Engels H; Sprengel R; Scherer SW; Rappold GA
    Nat Genet; 2010 Jun; 42(6):489-91. PubMed ID: 20473310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights into the generation and role of de novo mutations in health and disease.
    Acuna-Hidalgo R; Veltman JA; Hoischen A
    Genome Biol; 2016 Nov; 17(1):241. PubMed ID: 27894357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excess of de novo deleterious mutations in genes associated with glutamatergic systems in nonsyndromic intellectual disability.
    Hamdan FF; Gauthier J; Araki Y; Lin DT; Yoshizawa Y; Higashi K; Park AR; Spiegelman D; Dobrzeniecka S; Piton A; Tomitori H; Daoud H; Massicotte C; Henrion E; Diallo O; ; Shekarabi M; Marineau C; Shevell M; Maranda B; Mitchell G; Nadeau A; D'Anjou G; Vanasse M; Srour M; Lafrenière RG; Drapeau P; Lacaille JC; Kim E; Lee JR; Igarashi K; Huganir RL; Rouleau GA; Michaud JL
    Am J Hum Genet; 2011 Mar; 88(3):306-16. PubMed ID: 21376300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in DDX3X Are a Common Cause of Unexplained Intellectual Disability with Gender-Specific Effects on Wnt Signaling.
    Snijders Blok L; Madsen E; Juusola J; Gilissen C; Baralle D; Reijnders MR; Venselaar H; Helsmoortel C; Cho MT; Hoischen A; Vissers LE; Koemans TS; Wissink-Lindhout W; Eichler EE; Romano C; Van Esch H; Stumpel C; Vreeburg M; Smeets E; Oberndorff K; van Bon BW; Shaw M; Gecz J; Haan E; Bienek M; Jensen C; Loeys BL; Van Dijck A; Innes AM; Racher H; Vermeer S; Di Donato N; Rump A; Tatton-Brown K; Parker MJ; Henderson A; Lynch SA; Fryer A; Ross A; Vasudevan P; Kini U; Newbury-Ecob R; Chandler K; Male A; ; Dijkstra S; Schieving J; Giltay J; van Gassen KL; Schuurs-Hoeijmakers J; Tan PL; Pediaditakis I; Haas SA; Retterer K; Reed P; Monaghan KG; Haverfield E; Natowicz M; Myers A; Kruer MC; Stein Q; Strauss KA; Brigatti KW; Keating K; Burton BK; Kim KH; Charrow J; Norman J; Foster-Barber A; Kline AD; Kimball A; Zackai E; Harr M; Fox J; McLaughlin J; Lindstrom K; Haude KM; van Roozendaal K; Brunner H; Chung WK; Kooy RF; Pfundt R; Kalscheuer V; Mehta SG; Katsanis N; Kleefstra T
    Am J Hum Genet; 2015 Aug; 97(2):343-52. PubMed ID: 26235985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exome sequencing supports a de novo mutational paradigm for schizophrenia.
    Xu B; Roos JL; Dexheimer P; Boone B; Plummer B; Levy S; Gogos JA; Karayiorgou M
    Nat Genet; 2011 Aug; 43(9):864-8. PubMed ID: 21822266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in SYNGAP1 in autosomal nonsyndromic mental retardation.
    Hamdan FF; Gauthier J; Spiegelman D; Noreau A; Yang Y; Pellerin S; Dobrzeniecka S; Côté M; Perreau-Linck E; Carmant L; D'Anjou G; Fombonne E; Addington AM; Rapoport JL; Delisi LE; Krebs MO; Mouaffak F; Joober R; Mottron L; Drapeau P; Marineau C; Lafrenière RG; Lacaille JC; Rouleau GA; Michaud JL;
    N Engl J Med; 2009 Feb; 360(6):599-605. PubMed ID: 19196676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exome sequencing identifies a de novo SCN2A mutation in a patient with intractable seizures, severe intellectual disability, optic atrophy, muscular hypotonia, and brain abnormalities.
    Baasch AL; Hüning I; Gilissen C; Klepper J; Veltman JA; Gillessen-Kaesbach G; Hoischen A; Lohmann K
    Epilepsia; 2014 Apr; 55(4):e25-9. PubMed ID: 24579881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High diagnostic yield of syndromic intellectual disability by targeted next-generation sequencing.
    Martínez F; Caro-Llopis A; Roselló M; Oltra S; Mayo S; Monfort S; Orellana C
    J Med Genet; 2017 Feb; 54(2):87-92. PubMed ID: 27620904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical genomics expands the morbid genome of intellectual disability and offers a high diagnostic yield.
    Anazi S; Maddirevula S; Faqeih E; Alsedairy H; Alzahrani F; Shamseldin HE; Patel N; Hashem M; Ibrahim N; Abdulwahab F; Ewida N; Alsaif HS; Al Sharif H; Alamoudi W; Kentab A; Bashiri FA; Alnaser M; AlWadei AH; Alfadhel M; Eyaid W; Hashem A; Al Asmari A; Saleh MM; AlSaman A; Alhasan KA; Alsughayir M; Al Shammari M; Mahmoud A; Al-Hassnan ZN; Al-Husain M; Osama Khalil R; Abd El Meguid N; Masri A; Ali R; Ben-Omran T; El Fishway P; Hashish A; Ercan Sencicek A; State M; Alazami AM; Salih MA; Altassan N; Arold ST; Abouelhoda M; Wakil SM; Monies D; Shaheen R; Alkuraya FS
    Mol Psychiatry; 2017 Apr; 22(4):615-624. PubMed ID: 27431290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel de novo PCDH19 mutations in three unrelated females with epilepsy female restricted mental retardation syndrome.
    Jamal SM; Basran RK; Newton S; Wang Z; Milunsky JM
    Am J Med Genet A; 2010 Oct; 152A(10):2475-81. PubMed ID: 20830798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation analysis of the RSK2 gene in Coffin-Lowry patients: extensive allelic heterogeneity and a high rate of de novo mutations.
    Jacquot S; Merienne K; De Cesare D; Pannetier S; Mandel JL; Sassone-Corsi P; Hanauer A
    Am J Hum Genet; 1998 Dec; 63(6):1631-40. PubMed ID: 9837815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From the periphery to centre stage: de novo single nucleotide variants play a key role in human genetic disease.
    Ku CS; Tan EK; Cooper DN
    J Med Genet; 2013 Apr; 50(4):203-11. PubMed ID: 23396985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De Novo Mutations Affecting the Catalytic Cα Subunit of PP2A, PPP2CA, Cause Syndromic Intellectual Disability Resembling Other PP2A-Related Neurodevelopmental Disorders.
    Reynhout S; Jansen S; Haesen D; van Belle S; de Munnik SA; Bongers EMHF; Schieving JH; Marcelis C; Amiel J; Rio M; Mclaughlin H; Ladda R; Sell S; Kriek M; Peeters-Scholte CMPCD; Terhal PA; van Gassen KL; Verbeek N; Henry S; Scott Schwoerer J; Malik S; Revencu N; Ferreira CR; Macnamara E; Braakman HMH; Brimble E; Ruzhnikov MRZ; Wagner M; Harrer P; Wieczorek D; Kuechler A; Tziperman B; Barel O; de Vries BBA; Gordon CT; Janssens V; Vissers LELM
    Am J Hum Genet; 2019 Jan; 104(1):139-156. PubMed ID: 30595372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.